Payer PolicyActive
Vagus Nerve Stimulation (VNS) - (0350)
CIGNA-VNS
Cigna
Effective: February 15, 2025
Updated: December 6, 2025
created · Dec 2, 2025
Policy Summary
Cigna covers implantable VNS only for medically intractable seizures after documented failure, contraindication, or intolerance to all suitable medical and pharmacological management and requires appropriate coding and supporting documentation for reimbursement. All other indications (including MDD/treatment‑refractory depression) are excluded, transcutaneous VNS is not covered, and specific devices/codes (e.g., HCPCS C1822, CPT 97014/97032, HCPCS E0720) are considered not medically necessary or non‑reimbursable.
Coverage Criteria Preview
Key requirements from the full policy
"Vagus nerve stimulation (VNS) with an implantable vagus nerve stimulator is considered medically necessary for the treatment of medically intractable seizures when there is failure, contraindicatio..."
Sign up to see full coverage criteria, indications, and limitations.